ticker
Login
business news
Politics And Regulation
Markets
The Economy
Editor's Pick
trading and investing
Stocks
ETFs
Fixed Income
Earnings
Currencies
Commodities
Options
Taxes
Personal Finance
How To Trade
How To Invest
sectors
Biotech/pharma
Consumer
Energy
Financial
Global Markets
Media
Precious Metals
Real Estate
Technology
Transportation
special features
Wall Of Worry
Random Thoughts
Sports Business
Minyanville Press
Video
Hoofy & Boo
Radio
MV PREMIUM
subscriptions
Launch Buzz And Banter
Buzz And Banter
Elliott Wave Insider
Tchir's Fixed Income Report
Cooper's Market Report
Techstrat Report
Optionsmith
The Stock Playbook
Ad Free Minyanville
Minyanville Book Store
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Vivus, Inc.
(NQ:
VVUS
)
14.82
USD
+0.32 (+2.21%)
Official Closing Price
/ Updated:
8:10 PM EDT, May 24, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Vivus, Inc.
< Previous
1
2
3
4
5
6
7
8
9
...
76
77
Next >
A few stocks to watch next week
Today 4:14 EDT
category
BBRY
,
VHC
,
MRCY
, and 3 more.
from
AC Investor Blog
Bearish Speculators Show an Affinity for VIVUS, Inc. (VVUS)
May 24, 2013
Bearish trading activity has accelerated on VIVUS, Inc. (NASDAQ:VVUS), despite today's trek higher...( Read More )
Read More
category
VVUS
from
SchaeffersResearch.com Daily Market Blog
Sarissa Capital Shows New 1.99% Stake in Vivus, Inc. (VVUS), Denner Nominated to Board
May 24, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8368208 for the full story.
Read More
from
StreetInsider.com News Articles
NASDAQ Gainers Watch List: VIVUS Inc. (NASDAQ:VVUS), Theravance Inc. (NASDAQ:THRX), and Orexigen Therapeutics, Inc. (NASDAQ:OREX) Added to Growing Stock Report's NASDAQ Gainers Watch List.
May 24, 2013
New York, NY -- (SBWIRE) -- 05/24/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding VIVUS Inc. (NASDAQ:VVUS), Theravance Inc. (NASDAQ:THRX), and Orexigen Therapeutics,...
Read More
from
SBWire - Latest Press Releases
Free Research Reports on DOV, DRYS, PLCE and VVUS Issued by the Bedford Report
May 24, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT
Read More
from
Marketwired News Releases
UPDATE 1-Novo obesity drug could launch in U.S. end 2014
May 24, 2013
COPENHAGEN, May 24 (Reuters) - Danish drug maker Novo Nordisk said it could launch obesity treatment liraglutide in the United States by the end of next year and rejected some analysts' doubts over the...
Read More
category
companyNews
from
Reuters: Company News
3 Pharmaceutical Stocks to Sell Now
May 24, 2013
Read More
category
Stocks to Sell
,
NASDAQ:CORT
,
NASDAQ:CEMP
, and 1 more.
from
InvestorPlace - Latest Headlines
Denner added as nominee to Vivus board by activist investor
May 23, 2013
May 23 (Reuters) - First Manhattan Company (FMC) added some heavyweight muscle on Thursday to its bid to shake up the board of drugmaker Vivus Inc by naming former Carl Icahn top lieutenant Alex Denner...
Read More
category
companyNews
from
Reuters: Company News
Bio-Wire Equity Surveillance – Closing Bell 5/23/2013
May 23, 2013
Notable Jumps by % Gain and Mkt Cap Change Ariad Pharmaceuticals (NASDAQ: ARIA) +5.48% heads higher in reaction to ASCO abstracts and continued shift towards positive sentiment based on Iclusig sales...
Read More
category
CRMD
,
BLFS
,
Bio/Wire
, and 5 more.
from
Bio-Wire.Com
Bullish Two Hundred Day Moving Average Cross - VVUS
May 23, 2013
In trading on Thursday, shares of Vivus, Inc. (VVUS) crossed above their 200 day moving average of $14.90, changing hands as high as $15.04 per share.
Read More
category
Stocks
from
Market News Video
Vivus: Management’s Response and Updates
May 23, 2013
I contacted Vivus (NASDAQ: VVUS) directly in an attempt to reach company management to ask them about 10% shareholder First Manhattan’s stance against their efforts to market QSYMIA for patients with a...
Read More
category
Bio/Wire
,
VVUS
from
Bio-Wire.Com
NASDAQ Gainers Watch List: VIVUS Inc. (NASDAQ:VVUS), Theravance Inc. (NASDAQ:THRX), and Orexigen Therapeutics, Inc. (NASDAQ:OREX) Added to Equity Profile Report's NASDAQ Gainers Watch List.
May 23, 2013
Wilmington, DE -- (SBWIRE) -- 05/23/2013 -- Equity Profile Report expands its NASDAQ Gainers Weekly Watch List adding VIVUS Inc. (NASDAQ:VVUS), Theravance Inc. (NASDAQ:THRX), and Orexigen Therapeutics,...
Read More
from
SBWire - Latest Press Releases
Vivus Heats Up, Shorts Discouraged on Possible Bidding War
May 23, 2013
Vivus (NASDAQ: VVUS) has been seeing relatively modest growth in QSYMIA (phentermine and topiramate ER) prescriptions since the drug launched in September 2012 under the FDA’s REMS agreement, which...
Read More
category
Bio/Wire
,
VVUS
from
Bio-Wire.Com
Vivus (VVUS) Sees Upside on Icahn Connection
May 23, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8365254 for the full story.
Read More
from
StreetInsider.com News Articles
First Manhattan Adds Alex Denner to Vivus Board Slate
May 23, 2013
from
Business Wire News Releases
Options Update for VIVUS (VVUS)
May 23, 2013
NEW YORK (AVAFIN) -- During the last trading session, a new 90-day call record ...
Read More
from
AVAFIN
Stocks to Watch for May 23, 2013
May 22, 2013
category
LNKD
,
AMZN
,
VVUS
, and 1 more.
from
AC Investor Blog
VIVUS, Inc. (VVUS) to Make Several Scientific Presentations in May
May 22, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8360711 for the full story.
Read More
from
StreetInsider.com News Articles
VIVUS Announces Scientific Presentations
May 22, 2013
from
GlobeNewswire News Releases
QVT Financial Purchase $20M of Convertible Debt Issued by VIVUS (VVUS)
May 20, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8355998 for the full story.
Read More
from
StreetInsider.com News Articles
Enteromedics Rallies On Confirmed Path To Possible Approval
May 20, 2013
EnteroMedics (NASDAQ: ETRM) is a company that focuses on gastrointestinal and metabolic diseases with its flagship product VBLOC®, which is a first-in-class weight loss treatment that prevents obesity...
Read More
category
ETRM
,
Bio/Wire
from
Bio-Wire.Com
Earnings Look Back: Vivus Is Down 6.9% Since Reporting Quarterly Results 1 Week Ago (VVUS)
May 20, 2013
from
Comtex SmarTrend® News Briefs
3 Pharmaceutical Stocks to Sell Now
May 17, 2013
Read More
category
Stocks to Sell
,
NASDAQ:CORT
,
NASDAQ:CEMP
, and 1 more.
from
InvestorPlace - Latest Headlines
Free Research Reports on ARO, PLAB, VVUS and ZNGA Issued by the Paragon Report
May 16, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT
Read More
from
Marketwired News Releases
VIVUS (VVUS) Prices $220M Convertible Debt Offering
May 16, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8345549 for the full story.
Read More
from
StreetInsider.com News Articles
VIVUS Announces Pricing of Offering of $220 Million of 4.50% Convertible Senior Notes
May 16, 2013
from
GlobeNewswire News Releases
NASDAQ Decliners Watch List: Rockwell Medical, Inc. (NASDAQ:RMTI), VIVUS Inc. (NASDAQ:VVUS), and Orexigen Therapeutics, Inc. (NASDAQ:OREX) Added to Growing Stock Report's NASDAQ Decliners Watch List.
May 15, 2013
New York, NY -- (SBWIRE) -- 05/15/2013 -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding Rockwell Medical, Inc. (NASDAQ:RMTI), VIVUS Inc. (NASDAQ:VVUS), and Orexigen...
Read More
from
SBWire - Latest Press Releases
VIVUS (VVUS) Launches $200M Convertible Notes Offering
May 15, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8339301 for the full story.
Read More
from
StreetInsider.com News Articles
VIVUS Announces Proposed Offering of Convertible Senior Notes
May 15, 2013
from
GlobeNewswire News Releases
Vivus Downgraded Earlier by Lazard on News of Poorly Performing Treatment
May 14, 2013
Vivus (NASDAQ: VVUS ) is currently up nearly 2 percent despite being downgraded from Buy to Neutral at Lazard Capital Markets. Traders in Vivus are continuing to responding to news from Monday the...
Read More
category
Benzinga
,
Downgrades
,
Analyst Ratings
, and 1 more.
from
Latest Articles from Benzinga.com
< Previous
1
2
3
4
5
6
7
8
9
...
76
77
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Stay Connected
WHAT'S POPULAR IN THE VILLE
1
Google and NASA Make Quantum Leap With New Computer
Josh Wolonick
2
Random Thoughts: The Third Dip Cometh!
Todd Harrison
3
Random Thoughts: A Signal That Bears Watching
Todd Harrison
4
Google, Facebook, Yahoo, and Twitter: Web Giants Make Unexpected Announcements
Carol Kopp
5
Gold Mining Stocks: 10 Reasons It's Time to Be Brave
David Banister
See All Articles
»